TOVX
- Theriva Biologics, Inc.
()
Overview
Company Summary
Theriva Biologics, Inc. is a biotechnology company that specializes in the development and production of novel therapeutics derived from biological sources. The company focuses on harnessing the power of biologics, which are medical products derived from living organisms, to address unmet medical needs.
Theriva Biologics is known for its expertise in developing cutting-edge approaches and technologies for the production of therapeutic proteins and antibodies. These proteins and antibodies play a crucial role in various biological processes and have a wide range of applications in diagnosing and treating diseases, including cancer, autoimmune disorders, and infectious diseases.
The company's research and development efforts revolve around identifying and optimizing therapeutic targets, designing and engineering biologic medicines, and conducting preclinical and clinical trials to evaluate their safety and efficacy. They employ advanced technologies such as genetic engineering, protein expression systems, and antibody discovery platforms to create innovative biologic drugs.
Theriva Biologics works closely with pharmaceutical and biotechnology companies, academic institutions, and research organizations to collaborate on research projects and partnerships. They also engage in licensing agreements and collaborations to expedite the development of their therapies and expand their reach in the global market.
Overall, Theriva Biologics, Inc. is dedicated to advancing the field of biologics and delivering transformative therapies that have the potential to revolutionize the treatment of various diseases, ultimately improving patient outcomes and quality of life.